Alliance Capital Management L.P. (AB) 27.17 $AB
AllianceBernstein Holding's (AB) CEO Peter Kraus on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 12:18PM CST
AB: 27.17 (+0.47)
More on AllianceBernstein results
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 7:17AM CST
AB: 27.17 (+0.47)
AB Announces January 31, 2015 Assets Under Management
PR Newswire - Thu Feb 12, 6:06AM CST
AllianceBernstein L.P. ("AB"
and AllianceBernstein Holding L.P. ("AB Holding" (NYSE: AB) today announced that preliminary assets under management increased to $476 billion during January 2015 from $474 billion at the end of December. The 0.4% increase was the result of total firmwide net inflows during the month, partially offset by market depreciation, including the negative impact of FX movements. By channel, net flows were positive in Institutions and Private Wealth Management and flat in Retail.
AB: 27.17 (+0.47)
AllianceBernstein beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:50AM CST
AB: 27.17 (+0.47)
AllianceBernstein Holding L.P. Announces Fourth Quarter Results
PR Newswire - Thu Feb 12, 5:46AM CST
AllianceBernstein L.P. ("AB" and AllianceBernstein Holding L.P. ("AB Holding" (NYSE: AB) today reported financial and operating results for the fourth quarter ended December 31, 2014.
AB: 27.17 (+0.47)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
KKR Falls on Q4 Earnings Miss, Investment Income Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:24AM CST
KKR (KKR) reported adjusted economic net income per unit of 5 cents, substantially missing the Zacks Consensus Estimate of 40 cents. Moreover, the bottom line came in lower than the prior-year quarter figure of $1.04.
BAM: 54.40 (+0.93), AB: 27.17 (+0.47), FIG: 7.92 (+0.22), KKR: 24.42 (+0.06)
Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase
at The Street - Mon Feb 09, 7:53PM CST
History tells us that growth and progress are positives for the stock market, Cramer says, and this time will be no different.
FTR: 8.38 (+0.01), NUE: 48.90 (+0.55), WFC: 55.33 (+0.47), BMY: 60.04 (+0.56), XLU: 45.17 (-0.70), AB: 27.17 (+0.47), VRSK: 67.90 (+0.46), RIG: 19.05 (+0.42), GILD: 101.90 (+1.10), MPC: 103.48 (+2.08), MRO: 29.49 (+0.71), TAL: 41.00 (+0.37), TWTR: 48.50 (+0.55), X: 26.36 (+1.12)
AB Science: Positive Phase 2 Clinical Study Data of Masitinib in Second-Line Metastatic Stomach Cancer
GlobeNewswire - Mon Feb 02, 11:26AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), today announced encouraging efficacy and safety results from a phase 2 study with its investigational drug, masitinib, in patients with nonresectable, metastatic esophagogastric adenocarcinoma after progression to first-line treatment.
AB: 27.17 (+0.47)
AB to Report Fourth Quarter 2014 Results on Thursday, February 12, 2015
PR Newswire - Thu Jan 29, 12:15PM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that Fourth Quarter 2014 financial and operating results will be released on Thursday, February 12, 2015. Management will conduct a teleconference call beginning at 8:00 am (ET), following the release of its financial results. The call will be hosted by Peter S. Kraus, Chairman and Chief Executive Officer, and John C. Weisenseel, Chief Financial Officer.
AB: 27.17 (+0.47)
AllianceBernstein Launches New Branding Initiative
PR Newswire - Tue Jan 20, 6:50AM CST
AllianceBernstein L.P. ("AllianceBernstein" , a global investment management firm with US $474 billion in assets under management, today announced changes to its brand identity and messaging to better reflect the evolution of the firm. Over the past few years, the company has expanded across asset classes and markets, finding dynamic new ways to solve investors' challenges. Today, the firm is able to move its clients' vision forward like never before by offering a unique combination of industry-leading talent, an integrated global structure, a culture of collaboration, intense client focus and the ability to deliver differentiated results. This new brand initiative, Ahead of Tomorrow, captures both the company's progress and its unique approach to innovating and delivering for clients. The new brand name, "AB," and logo better embody the firm's distinct offerings and unified culture.
AB: 27.17 (+0.47)
AllianceBernstein AUM fall in December
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 8:04AM CST
AB: 27.17 (+0.47)
AllianceBernstein Announces December 31, 2014 Assets Under Management
PR Newswire - Wed Jan 14, 7:54AM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that preliminary assets under management decreased to $474 billion during December 2014 from $481 billion at the end of November. The 1.5% decrease was due to market depreciation and net outflows during the month across all three distribution channels.
AB: 27.17 (+0.47)
AB Science: The Data and Safety Monitoring Board Recommends the Continuation of Phase 3 Study of Masitinib in Amyotrophic Lateral Sclerosis
GlobeNewswire - Tue Jan 13, 10:48AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), announces that the external Data and Safety Monitoring Board (DSMB) has recommended the continuation of its phase 3 study of masitinib in amyotrophic lateral sclerosis (ALS) based upon review of the latest safety data. The DSMB was created as part of the Company's pivotal clinical study evaluating masitinib in the treatment of amyotrophic lateral sclerosis.
AB: 27.17 (+0.47)
3 Buy-Rated Dividend Stocks: DMLP, MAIN, AB
at The Street - Thu Jan 08, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
DMLP: 25.75 (+0.41), AB: 27.17 (+0.47), MAIN: 30.82 (+0.23)
AllianceBernstein Launches Multi-Manager Target-Date Series Co-managed with Morningstar Associates
PR Newswire - Wed Jan 07, 9:36AM CST
AllianceBernstein L.P. (AllianceBernstein), a global investment management firm with $481 billion in assets under management, today announced that its multi-manager target-date series, AB Multi-Manager Select Retirement Funds, co-managed with Morningstar Associates, LLC, a registered investment advisor and wholly owned subsidiary of Morningstar, Inc., is now available to investors.
AB: 27.17 (+0.47), MORN: 78.24 (+2.16)
My 2014 Best Performers, Looking Ahead To 2015
Michael J. Bernard - at Seeking Alpha - Tue Jan 06, 6:34AM CST
KMI: 41.97 (+0.21), MMM: 165.94 (+0.03), PRGO: 150.90 (+0.22), LMT: 196.95 (-0.53), DUK: 79.84 (-1.22), LO: 67.30 (-0.80), SDRL: 12.32 (-0.70), SRE: 105.56 (-1.11), INTC: 34.36 (+0.23), ANH: 5.16 (+0.06), QCOM: 70.88 (+0.49), AMAT: 24.12 (-0.02), NAT: 10.20 (+0.10), ABBV: 58.05 (+1.00), FL: 53.96 (-0.13), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), RAI: 71.86 (-1.23), FRO: 2.96 (+0.07), NSC: 109.91 (-0.17), CYS: 8.78 (+0.04), MO: 54.76 (-0.78), CSX: 36.08 (-0.49), SO: 45.88 (-0.68), HRZN: 14.22 (+0.16), CELG: 115.88 (+0.16), WBA: 78.73 (-1.23), AB: 27.17 (+0.47), CTB: 36.73 (-0.29), CNI: 70.04 (-0.39), AZN: 69.96 (+0.20), MGA: 102.32 (-0.46), ULTA: 136.66 (+0.59), CP: 186.30 (-0.54), KLAC: 63.64 (-0.23), BRK.B: 148.34 (-1.45)
The 6 Best and Worst Asset Manager Stocks if Oil Prices Stay Low in 2015
at The Street - Wed Dec 31, 11:51AM CST
Lower oil prices are creating investment opportunities for alternative asset managers, but some traditional asset managers will be challenged, says a recent report from Morgan Stanley.
OAK: 57.07 (+1.39), CG: 28.18 (+0.04), BX: 37.40 (+0.49), APO: 23.70 (+0.36), AB: 27.17 (+0.47), KKR: 24.42 (+0.06), MS: 36.78 (-0.12)
AllianceBernstein Announces November 30, 2014 Assets Under Management
PR Newswire - Wed Dec 10, 3:08PM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that preliminary assets under management increased to $481 billion during November 2014 from $477 billion at the end of October. The 0.8% increase was due to market appreciation and total firmwide net inflows during the month. By channel, net flows were positive for Institutions, flat for Private Client and negative for Retail.
AB: 27.17 (+0.47)
AB Science advances Ultra-Selective SYK Kinase Inhibitor into Full Preclinical Development
GlobeNewswire - Fri Nov 28, 10:58AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), reported the advancement of a novel, small molecule SYK kinase inhibitor named AB8779 into full preclinical development.
AB: 27.17 (+0.47)
AllianceBernstein Holding's (AB) CEO Peter Kraus on Q4 2014 Results - Earnings Call Transcript
SA Transcripts - at Seeking Alpha - Thu Feb 12, 12:18PM CST
AB: 27.17 (+0.47)
More on AllianceBernstein results
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 7:17AM CST
AB: 27.17 (+0.47)
AB Announces January 31, 2015 Assets Under Management
PR Newswire - Thu Feb 12, 6:06AM CST
AllianceBernstein L.P. ("AB"
and AllianceBernstein Holding L.P. ("AB Holding" (NYSE: AB) today announced that preliminary assets under management increased to $476 billion during January 2015 from $474 billion at the end of December. The 0.4% increase was the result of total firmwide net inflows during the month, partially offset by market depreciation, including the negative impact of FX movements. By channel, net flows were positive in Institutions and Private Wealth Management and flat in Retail. AB: 27.17 (+0.47)
AllianceBernstein beats by $0.06, beats on revenue
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:50AM CST
AB: 27.17 (+0.47)
AllianceBernstein Holding L.P. Announces Fourth Quarter Results
PR Newswire - Thu Feb 12, 5:46AM CST
AllianceBernstein L.P. ("AB"
and AllianceBernstein Holding L.P. ("AB Holding" (NYSE: AB) today reported financial and operating results for the fourth quarter ended December 31, 2014. AB: 27.17 (+0.47)
Notable earnings before Thursday’s open
Seeking Alpha - at Seeking Alpha - Wed Feb 11, 4:30PM CST
NLSN: 45.59 (+2.02), RTIX: 5.54 (+0.19), AAP: 150.16 (-1.26), JAH: 51.18 (+0.18), LMNS: 10.80 (+0.57), THS: 80.00 (-1.57), RWLK: 17.40 (-0.77), CAB: 53.55 (+1.23), FAF: 37.00 (+0.10), HSP: 87.35 (unch), PNK: 25.64 (-0.35), MFA: 7.89 (unch), SPW: 87.37 (-2.81), MFC: 17.31 (+0.27), HIMX: 8.04 (+0.28), LNCE: 30.72 (-0.25), TIME: 24.84 (+0.35), AVP: 9.08 (+0.39), INCY: 75.94 (+0.28), NNN: 41.00 (+0.20), NWE: 53.61 (-0.85), COR: 48.08 (+1.08), MHFI: 102.19 (unch), NCI: 14.99 (-0.01), BWA: 60.17 (-1.21), HERO: 0.92 (+0.02), NRP: 7.86 (-0.45), STC: 37.85 (+0.23), AB: 27.17 (+0.47), CPLA: 65.23 (-1.37), TU: 34.83 (+0.01), IFF: 116.96 (+2.19), GNC: 48.11 (-0.55), MINI: 40.62 (-0.83), ACOR: 36.14 (-0.51), CVE: 19.42 (-0.29), SNI: 73.00 (+0.39), CCE: 43.69 (-0.66), K: 63.20 (-0.10), DPS: 76.95 (-1.35), BG: 82.22 (+1.78), AAWW: 48.01 (+0.44), Q: 63.31 (+0.06), SHPG: 239.82 (+6.11), MANU: 17.20 (-0.21), MPEL: 27.54 (+0.78), APA: 67.05 (+2.47), DBD: 35.82 (+1.07), MPW: 14.64 (+0.14), HE: 33.14 (-0.22), RYN: 28.02 (-1.15), CS: 23.65 (+0.23), PDS: 6.04 (+0.12), ANR: 1.27 (+0.03), SON: 46.65 (-0.79), SKYW: 13.84 (+1.88), LPNT: 69.04 (-0.06), RDN: 16.10 (-0.43), MDWD: 7.22 (+0.17), SCOR: 53.35 (-1.10), FLO: 21.68 (+0.38)
KKR Falls on Q4 Earnings Miss, Investment Income Down - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Wed Feb 11, 8:24AM CST
KKR (KKR) reported adjusted economic net income per unit of 5 cents, substantially missing the Zacks Consensus Estimate of 40 cents. Moreover, the bottom line came in lower than the prior-year quarter figure of $1.04.
BAM: 54.40 (+0.93), AB: 27.17 (+0.47), FIG: 7.92 (+0.22), KKR: 24.42 (+0.06)
Jim Cramer's 'Mad Money' Recap: Stop Worrying About the Fed Rate Increase
at The Street - Mon Feb 09, 7:53PM CST
History tells us that growth and progress are positives for the stock market, Cramer says, and this time will be no different.
FTR: 8.38 (+0.01), NUE: 48.90 (+0.55), WFC: 55.33 (+0.47), BMY: 60.04 (+0.56), XLU: 45.17 (-0.70), AB: 27.17 (+0.47), VRSK: 67.90 (+0.46), RIG: 19.05 (+0.42), GILD: 101.90 (+1.10), MPC: 103.48 (+2.08), MRO: 29.49 (+0.71), TAL: 41.00 (+0.37), TWTR: 48.50 (+0.55), X: 26.36 (+1.12)
AB Science: Positive Phase 2 Clinical Study Data of Masitinib in Second-Line Metastatic Stomach Cancer
GlobeNewswire - Mon Feb 02, 11:26AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), today announced encouraging efficacy and safety results from a phase 2 study with its investigational drug, masitinib, in patients with nonresectable, metastatic esophagogastric adenocarcinoma after progression to first-line treatment.
AB: 27.17 (+0.47)
AB to Report Fourth Quarter 2014 Results on Thursday, February 12, 2015
PR Newswire - Thu Jan 29, 12:15PM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that Fourth Quarter 2014 financial and operating results will be released on Thursday, February 12, 2015. Management will conduct a teleconference call beginning at 8:00 am (ET), following the release of its financial results. The call will be hosted by Peter S. Kraus, Chairman and Chief Executive Officer, and John C. Weisenseel, Chief Financial Officer.
AB: 27.17 (+0.47)
AllianceBernstein Launches New Branding Initiative
PR Newswire - Tue Jan 20, 6:50AM CST
AllianceBernstein L.P. ("AllianceBernstein"
, a global investment management firm with US $474 billion in assets under management, today announced changes to its brand identity and messaging to better reflect the evolution of the firm. Over the past few years, the company has expanded across asset classes and markets, finding dynamic new ways to solve investors' challenges. Today, the firm is able to move its clients' vision forward like never before by offering a unique combination of industry-leading talent, an integrated global structure, a culture of collaboration, intense client focus and the ability to deliver differentiated results. This new brand initiative, Ahead of Tomorrow, captures both the company's progress and its unique approach to innovating and delivering for clients. The new brand name, "AB," and logo better embody the firm's distinct offerings and unified culture. AB: 27.17 (+0.47)
AllianceBernstein AUM fall in December
Seeking Alpha - at Seeking Alpha - Wed Jan 14, 8:04AM CST
AB: 27.17 (+0.47)
AllianceBernstein Announces December 31, 2014 Assets Under Management
PR Newswire - Wed Jan 14, 7:54AM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that preliminary assets under management decreased to $474 billion during December 2014 from $481 billion at the end of November. The 1.5% decrease was due to market depreciation and net outflows during the month across all three distribution channels.
AB: 27.17 (+0.47)
AB Science: The Data and Safety Monitoring Board Recommends the Continuation of Phase 3 Study of Masitinib in Amyotrophic Lateral Sclerosis
GlobeNewswire - Tue Jan 13, 10:48AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specialized in research, development and marketing of protein kinase inhibitors (PKIs), announces that the external Data and Safety Monitoring Board (DSMB) has recommended the continuation of its phase 3 study of masitinib in amyotrophic lateral sclerosis (ALS) based upon review of the latest safety data. The DSMB was created as part of the Company's pivotal clinical study evaluating masitinib in the treatment of amyotrophic lateral sclerosis.
AB: 27.17 (+0.47)
3 Buy-Rated Dividend Stocks: DMLP, MAIN, AB
at The Street - Thu Jan 08, 9:30AM CST
These 3 dividend stocks are rated a Buy by TheStreet
DMLP: 25.75 (+0.41), AB: 27.17 (+0.47), MAIN: 30.82 (+0.23)
AllianceBernstein Launches Multi-Manager Target-Date Series Co-managed with Morningstar Associates
PR Newswire - Wed Jan 07, 9:36AM CST
AllianceBernstein L.P. (AllianceBernstein), a global investment management firm with $481 billion in assets under management, today announced that its multi-manager target-date series, AB Multi-Manager Select Retirement Funds, co-managed with Morningstar Associates, LLC, a registered investment advisor and wholly owned subsidiary of Morningstar, Inc., is now available to investors.
AB: 27.17 (+0.47), MORN: 78.24 (+2.16)
My 2014 Best Performers, Looking Ahead To 2015
Michael J. Bernard - at Seeking Alpha - Tue Jan 06, 6:34AM CST
KMI: 41.97 (+0.21), MMM: 165.94 (+0.03), PRGO: 150.90 (+0.22), LMT: 196.95 (-0.53), DUK: 79.84 (-1.22), LO: 67.30 (-0.80), SDRL: 12.32 (-0.70), SRE: 105.56 (-1.11), INTC: 34.36 (+0.23), ANH: 5.16 (+0.06), QCOM: 70.88 (+0.49), AMAT: 24.12 (-0.02), NAT: 10.20 (+0.10), ABBV: 58.05 (+1.00), FL: 53.96 (-0.13), MSFT: 43.87 (+0.78), AAPL: 127.08 (+0.62), UNP: 122.60 (-1.23), RAI: 71.86 (-1.23), FRO: 2.96 (+0.07), NSC: 109.91 (-0.17), CYS: 8.78 (+0.04), MO: 54.76 (-0.78), CSX: 36.08 (-0.49), SO: 45.88 (-0.68), HRZN: 14.22 (+0.16), CELG: 115.88 (+0.16), WBA: 78.73 (-1.23), AB: 27.17 (+0.47), CTB: 36.73 (-0.29), CNI: 70.04 (-0.39), AZN: 69.96 (+0.20), MGA: 102.32 (-0.46), ULTA: 136.66 (+0.59), CP: 186.30 (-0.54), KLAC: 63.64 (-0.23), BRK.B: 148.34 (-1.45)
The 6 Best and Worst Asset Manager Stocks if Oil Prices Stay Low in 2015
at The Street - Wed Dec 31, 11:51AM CST
Lower oil prices are creating investment opportunities for alternative asset managers, but some traditional asset managers will be challenged, says a recent report from Morgan Stanley.
OAK: 57.07 (+1.39), CG: 28.18 (+0.04), BX: 37.40 (+0.49), APO: 23.70 (+0.36), AB: 27.17 (+0.47), KKR: 24.42 (+0.06), MS: 36.78 (-0.12)
AllianceBernstein Announces November 30, 2014 Assets Under Management
PR Newswire - Wed Dec 10, 3:08PM CST
AllianceBernstein L.P. and AllianceBernstein Holding L.P. (NYSE: AB) today announced that preliminary assets under management increased to $481 billion during November 2014 from $477 billion at the end of October. The 0.8% increase was due to market appreciation and total firmwide net inflows during the month. By channel, net flows were positive for Institutions, flat for Private Client and negative for Retail.
AB: 27.17 (+0.47)
AB Science advances Ultra-Selective SYK Kinase Inhibitor into Full Preclinical Development
GlobeNewswire - Fri Nov 28, 10:58AM CST
AB Science SA (NYSE Euronext - FR0010557264 - AB), a pharmaceutical company specializing in the research, development and commercialization of protein kinase inhibitors (PKIs), reported the advancement of a novel, small molecule SYK kinase inhibitor named AB8779 into full preclinical development.
AB: 27.17 (+0.47)
